Download PDF
Geburtshilfe Frauenheilkd 2003; 63(8): 737-742
DOI: 10.1055/s-2003-42141
Übersicht

Georg Thieme Verlag Stuttgart · New York

Niedrig maligne endometriale Stromasarkome

Low-Grade Endometrial Stromal SarcomasO. Reich 1 , S. Regauer 2
  • 1Geburtshilflich-gynäkologische Universitätsklinik der Universität Graz, Österreich
  • 2Institut für Pathologie der Universität Graz, Österreich
Further Information

Publication History

Eingang Manuskript: 23. Januar 2003 Eingang revidiertes Manuskript: 22. März 2003

Akzeptiert: 2. April 2003

Publication Date:
16 September 2003 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Niedrig maligne endometriale Stromasarkome (NMESS) sind seltene sexualhormonabhängige Tumoren zumeist prämenopausaler Frauen. Sie kommen im Uterus und im Ovar, sehr selten auch in anderer Lokalisation vor. Die primäre Therapie ist chirurgisch. Standardoperation ist eine abdominale Hysterektomie mit bilateraler Salpingoophorektomie. Adjuvant ist in Abhängigkeit der Expression von Hormonrezeptoren eine Hormontherapie indiziert. Erfahrungen liegen mit Gestagenen und GNRH-Analoga vor. Der Benefit einer postoperativen Bestrahlung auf das Gesamtüberleben der Patientinnen ist bisher nicht bewiesen, ein effektives Chemotherapieregime nicht bekannt. Wichtigster Prognosefaktor ist das Tumorstadium. Bis zu 50 % aller NMESS rezidivieren. Die hohe Rezidivrate wird durch während der Operation zurückgelassene Tumorreste, die von der körpereigenen humoralen Abwehr nicht zerstört werden können, erklärt. Eine der anatomischen Ausbreitung angepasste Radikalität der operativen Behandlung ist deshalb ebenso notwendig wie eine lebenslange Tumornachsorge der Patientinnen.

Abstract

Low-grade endometrial stromal sarcomas (LGESS) are rare steroid-hormone dependent neoplasms, most of which arise in the uterus and ovaries of premenopausal women. If an LGESS is diagnosed preoperatively, hysterectomy with bilateral salpingoophorectomy is considered the standard therapy. For prognosis, tumor stage is the most important factor. Patients with LGESS suffer from a high recurrence rate up to 50 % which is believed to result from residual microscopic tumor islands. Adjuvant hormonal therapy may be indicated if the LGESS expresses hormone receptors. First promising results have been obtained with gestagen and GNRH-analoga therapy. Radiation therapy has no beneficial effect on overall survival, and an effective chemotherapy schema does not exist. Optimal treatment of patients is radical surgery and life-long oncological follow-up.

Schlüsselwörter

Uterus - Endometrium - Sarkom - Östrogenrezeptor - Progesteronrezeptor - Hormontherapie

Key words

Uterus - endometrium - sarcoma - oestrogen receptor - progesterone receptor - hormonal therapy

Literatur

  • 1 Baggish M S, Woodruff J D. Uterine stromatosis: clinicopathologic features and hormone dependency.  Obstet Gynecol. 1972;  40 487-498
    PubMedGoogle Scholar
  • 2 Baiocchi G, Kavanagh J J, Warton J T. Endometrioid stromal sarcomas arising from ovarian and extraovarian endometriosis: report of two cases and review of the literature.  Gynecol Oncol. 1990;  36 147-151
    CrossrefPubMedGoogle Scholar
  • 3 Beckmann M W, Jap D, Kuschel B, Dall P, Lux M P, Hanstein B, Bender H G. Ovarielle Steroidhormone und Anti-Östrogene: Risiken zu und Prävention in der Karzinogenese der Mamma und des Endometriums in der Postmenopause.  Geburtsh Frauenheilk. 2000;  60 77-85
    PubMedGoogle Scholar
  • 4 Beckmann M W, Hanstein B, Niederacher D, Jap D, Kuschel B, Bender H G. Wirkmechanismen ovarieller Antiöstrogene in der Karzinogenese der Mamma und des Endometriums.  Geburtsh Frauenheilk. 2000;  60 71-76
    PubMedGoogle Scholar
  • 5 Baker V V, Walton L A, Fowler W C, Currie J L. Steroid receptors in endolymphatic stromal myosis.  Obstet Gynecol. 1984;  63 72-74
    PubMedGoogle Scholar
  • 6 Berchuck A, Rubin S C, Hoskins W J, Saigo P E, Pierce V K, Lewis Jr J L. Treatment of endometrial stromal tumors.  Gynecol Oncol. 1990;  36 60-65
    CrossrefPubMedGoogle Scholar
  • 7 Chang K L, Crabtree G S, Lim Tan S K, Kempson R L, Hendrickson M R. Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature.  Int J Gynecol Pathol. 1993;  12 282-296
    PubMedGoogle Scholar
  • 8 Chang K L, Crabtree G S, Lim-Tan S K, Kempson R L, Hendrickson M R. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases.  Am J Surg Pathol. 1990;  14 415-438
    CrossrefPubMedGoogle Scholar
  • 9 Cummings S R, Eckert S, Krueger K A, Grady D, Powels T J, Cauley J A, Norton L, Nickelsen T, Bjarnason N H, Morrow M, Lippmann M E, Black D, Glusman J E, Costa A, Jordan V C. The effect of raloxifen on risk of breast cancer in postmenopausal women. Results from the MORE randomized trial.  JAMA. 1999;  281 2189-2197
    CrossrefPubMedGoogle Scholar
  • 10 Dorran A, Lockayer C. Two of cases of uterine fibroids showing peritheliomatous changes: long immunity from recurrence after operation.  Proc R Soc Med. 1908;  2 25-39
    PubMedGoogle Scholar
  • 11 Echt G, Jepson J, Steel J, Langholz B, Luxton G, Hernandez W, Astrahan M, Petrovich Z. Treatment of uterine sarcomas.  Cancer. 1990;  66 35-39
    CrossrefPubMedGoogle Scholar
  • 12 Eddy G L, Mazur M T. Endolymphatic stromal myosis associated with tamoxifen use.  Gynecol Oncol. 1997;  64 262-264
    CrossrefPubMedGoogle Scholar
  • 13 Eldar-Geva T, Healy D L. Other medical management of uterine fibroids.  Baillieres Clin Obstet Gynaecol. 1998;  12 269-288
    PubMedGoogle Scholar
  • 14 Füzesi L, Gunawan B, Braun S, Karl M C. Endometrial stromal sarcoma with clonal chromosomal aberrations and mixed phenotype.  Cancer Genet Cytogenet. 1995;  84 85-88
    CrossrefPubMedGoogle Scholar
  • 15 Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A, Lissoni A, Losga G, Fanucci A. Endometrial stromal sarcoma: Analysis of treatment failures and survival.  Gynecol Oncol. 1996;  63 247-253
    CrossrefPubMedGoogle Scholar
  • 16 Gloor E, Schneyder P, Cikes M, Hofstetter J, Cordey R, Burnier F, Knobel P. Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomy.  Cancer. 1982;  50 1888-1893
    PubMedGoogle Scholar
  • 17 Hendrickson M R, Kempson R L. Pure mesenchymal neoplasms of the uterine corpus. Fox H, Wells M Haines and Taylos Obstetrical and Gynecological Pathology. New York; Churchill Livingstone 1995: 19-86
    Google Scholar
  • 18 Horowitz K, Rutherford T, Schwartz P E. Hormone replacement therapy in women with sarcomas.  CME J Gynecol Oncol. 1996;  1 23-29
    PubMedGoogle Scholar
  • 19 Iliszko M, Mandahl N, Mrozek K, Denis A, Padis N, Pejovic T, Babinska M, Nedoszytko B, Debniak Jm Emerich J, Hranowska M, Bloomfield C D, Limon J. Cytogenetics of uterine sarcomas: Presentation of eight new cases and review of the literature.  Gynecol Oncol. 1998;  71 172-176
    CrossrefPubMedGoogle Scholar
  • 20 Kahanpaa K V, Wahlström T, Gröhn P, Heinonen E, Nieminen U, Widholm O. Sarcomas of the uterus: a clinicopathologic study of 119 patients.  Obstet Gynecol. 1986;  67 417-423
    PubMedGoogle Scholar
  • 21 Katz L, Merino M J, Sakamoto H, Schwarz P E. Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors.  Gynecol Oncol. 1987;  26 87-97
    CrossrefPubMedGoogle Scholar
  • 22 Keen C E, Philip G. Progesterone-induced regression in low-grade endometrial stromal sarcoma. Case report and literature review.  Br J Obstet Gynaecol. 1989;  96 1435-1439
    PubMedGoogle Scholar
  • 23 Knocke T H, Kucera H, Dörfler D, Pokrajac B, Pötter R. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.  Cancer. 1998;  83 1972-1979
    CrossrefPubMedGoogle Scholar
  • 24 Krieger P D, Gusberg S B. Endolymphatic stromal myosis - a grade I endometrial sarcoma.  Gynecol Oncol. 1973;  1 299-313
    CrossrefPubMedGoogle Scholar
  • 25 Krumholz B A, Lobovsky F Y, Halitsky V. Endolymphatic stromal myosis with pulmonary metastases. Remission with progestin therapy: Report of a case.  J Reprod Med. 1973;  10 85-89
    PubMedGoogle Scholar
  • 26 Larson B, Silfversward C, Nielsson B, Pettersson F. Endometrial stromal sarcoma of the uterus. A clinical and histopathologic study. The Radiumhemmet series 1936 - 1981.  Europ J Obstet Gynecol Reprod Biol. 1990;  35 239-249
    PubMedGoogle Scholar
  • 27 Lehrner L M, Miles P A, Enck R E. Complete remission of widely metastatic endometrial stromal sarcoma following combination chemotherapy.  Cancer. 1979;  43 1189-1194
    PubMedGoogle Scholar
  • 28 Liokumovic P, Goldberg I, Davidson B, Gotlieb W H, Zahavi T, Ben-Baruch G, Reder I, Kopolovic J. Expression of metalloproteinases in endometrial stromal sarcoma: immunohistochemical study using image analysis.  J Clin Pathol. 1999;  52 198-202
    PubMedGoogle Scholar
  • 29 Luo S, Martel C, Gauthier S, Merand Y, Belanger A, Labrie C, Labrie F. Long term effects of a novel anti-estrogen on the growth of ZR-75-1 and MCF-7 human breast cancer tumors in nude mice.  Int J Cancer. 1997;  73 735-739
    CrossrefPubMedGoogle Scholar
  • 30 Mansi J L, Ramachandra S, Wiltshaw E, Fischer C. Endometrial stromal sarcomas.  Gynecol Oncol. 1990;  36 113-118
    CrossrefPubMedGoogle Scholar
  • 31 Mesia A F, Demopoulos R I. Effects of leuprolide acetate on low-grade endometrial stromal sarcoma.  Am J Obstet Gynecol. 2000;  182 1140-1141
    CrossrefPubMedGoogle Scholar
  • 32 Miller W R, Mullen P, Telford J, Dixon J M. Clinical importance of intratumoral aromatase.  Breast Canc Res Treat. 1998;  49 27-32
    PubMedGoogle Scholar
  • 33 Montag T W, Manart F D. Endolymphatic stromal myosis: surgical and hormonal therapy for extensive venous recurrence.  Gynecol Oncol. 1989;  33 255-260
    CrossrefPubMedGoogle Scholar
  • 34 Norris H J, Tayler H B. Mesenchymal tumors of the uterus I. A clinical and pathologic study of 53 endometrial stromal tumors.  Cancer. 1966;  19 755-766
    CrossrefPubMedGoogle Scholar
  • 35 Pang L C. Endometrial stromal sarcoma with sex cord-like differentiation associated with tamoxifen therapy.  South Med J. 1998;  91 592-594
    PubMedGoogle Scholar
  • 36 Pellillo D. Proliferative stromatosis of the uterus with pulmonary metastases. Remission following treatment with a long acting synthetic progestin: A case report.  Obstet Gynecol. 1968;  31 33-39
    PubMedGoogle Scholar
  • 37 Piver M S, Rutledge F N, Copeland L, Webster K, Blumenson L, Suh O. Uterine endolymphatic stromal myosis: a collaborative study.  Obstet Gynecol. 1984;  64 173-178
    PubMedGoogle Scholar
  • 38 Press M F, Scully R E. Endometrial “sarcomas” complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy.  Gynecol Oncol. 1985;  21 135-154
    CrossrefPubMedGoogle Scholar
  • 39 Rand R J, Lowe J W. Low-grade endometrial sarcoma treated with a progestagen.  Br J Hosp Med. 1990;  43 154-156
    PubMedGoogle Scholar
  • 40 Reich O, Pickel H, Regauer S. Cytologic diagnosis of low-grade endometrial stromal sarcoma by staining for estrogen- and progesterone receptors.  Acta Cytol. 2002;  46 790-792
    PubMedGoogle Scholar
  • 41 Reich O, Regauer S, Urdl M. Estrogen and progesterone receptor content in low-grade-stromal sarcomas.  Br J Cancer. 2000;  82 1030-1034
    CrossrefPubMedGoogle Scholar
  • 42 Reich O, Roitzsch E, Justus J. Die sogenannte Stromatosis uteri - ein niedrig malignes Sarkom - morphologische Studie anhand von 8 Falldarstellungen.  Zentralbl Gynäkol. 1994;  116 581-587
    PubMedGoogle Scholar
  • 43 Remmele W, Schicketanz K H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer: computer-assisted image analysis (QIC score) vs. subjective grading (IRS).  Pathol Res Pract. 1993;  189 862-866
    PubMedGoogle Scholar
  • 44 Scribiner D R, Walker H. Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Mecane.  Gynecol Oncol. 1998;  71 458-460
    CrossrefPubMedGoogle Scholar
  • 45 Scully R E, Bonfiglio T A, Kurman R J, Silverberg S G, Wilkinson E J. Histological Typing of Femal Genital Tract Tumors. Berlin; Springer 1994
    Google Scholar
  • 46 Scully R E, Young R H, Clement P B. Tumors of the Ovary, Maldeveloped Gonads, Fallopian Tube and Broad Ligament. Washington; Armed Forces Institute of Pathology 1998
    Google Scholar
  • 47 Seidmann J D, Russel P, Kurmann R J. Surface epithelial tumors of the ovary. Kurmann RJ Blaustein's Pathology of the Female Genital Tract. Berlin; Springer 2001
    Google Scholar
  • 48 Shiraki M, Otis C N, Powell J L. Endometrial stromal sarcoma arising from ovarian and extraovarian endometriosis - report of two cases and review of the literature.  Surg Pathol. 1991;  4 333-343
    PubMedGoogle Scholar
  • 49 Silverberg S B, Kurman R J. Tumors of the Uterine Corpus and Gestational Throphoblastic Disease. Washington; Armed Forces Institute of Pathology 1992
    Google Scholar
  • 50 Sonobe H, Iwata J, Furihata M, Ohtsuki Y, Taguchi T, Shimizu K. Endometrial stromal sarcoma with clonal complex chromosomal abnormalities.  Cancer Genet Cytogenet. 1999;  112 34-37
    CrossrefPubMedGoogle Scholar
  • 51 Sood A K, Sorosky J I, Gelder M S, Buller R E, Anderson B, Wilkinson E J, Benda J A, Morgan L S. Primary ovarian sarcoma. Analysis od prognostic variables and the role of surgical cytoreduction.  Cancer. 1998;  82 1731-1737
    CrossrefPubMedGoogle Scholar
  • 52 Styron S L, Burke T W, Linville W K. Low-grade endometrial stromal sarcoma recurring over three decades.  Gynecol Oncol. 1989;  35 275-278
    CrossrefPubMedGoogle Scholar
  • 53 Tsukamoto N, Kamura T, Matsukuma K, Imachi M, Uchino H, Saito T, Ono M. Endolymphatic stromal myosis: a case with positive estrogen and progesterone receptors and good responce to progestins.  Gynecol Oncol. 1985;  20 120-128
    CrossrefPubMedGoogle Scholar
  • 54 Walton L A, Siegfried J M, Nelson K G, Siegal G, Kaufmann D G. Endometrial stromal cells in culture: an attempt to understand the genesis and biologic activity of uterine sarcomas.  Gynecol Oncol. 1986;  24 247-257
    CrossrefPubMedGoogle Scholar
  • 55 Young R H, Prat J, Scully R E. Endometrioid stromal sarcomas of the ovary: a clinicopathologic analysis of 23 cases.  Cancer. 1984;  53 1143-1155
    PubMedGoogle Scholar
  • 56 Zaloudek C, Hendrickson M R. Mesenchymal tumors of the uterus. Kurmann RJ Blaustein's Pathology of the Female Genital Tract. Berlin; Springer 2001
    Google Scholar

Ao. Univ.-Prof. Dr. Olaf Reich

Klinische Abteilung für Gynäkologie und Geburtshilfe der Geburtshilflich-gynäkologischen Universitätsklinik Graz

Auenbruggerplatz 14

8036 Graz

Österreich

Email: olaf.reich@kfunigraz.ac.at

      >